-       Report 
- October 2025
-  377 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- November 2024
-  478 Pages 
- Global 
   From       €4428EUR$4,950USD£3,895GBP 
          -       Report 
- February 2025
-  454 Pages 
- Global 
   From       €4292EUR$4,799USD£3,776GBP 
            -       Report 
- October 2025
-  186 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
             -       Report 
- August 2025
-  185 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  186 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- November 2025
-  399 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  214 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  273 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- April 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- April 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- January 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Report 
- March 2025
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
      €4338EUR$4,850USD£3,816GBP 
          -       Report 
- November 2024
-  66 Pages 
- Global 
   From       €1744EUR$1,950USD£1,534GBP 
          -       Report 
- April 2025
-  73 Pages 
- Global 
   From       €8940EUR$9,995USD£7,864GBP 
          -       Report 
- July 2020
-  215 Pages 
- Global 
   From       €4382EUR$4,899USD£3,854GBP 
       
      Drug repositioning is a process of discovering new therapeutic uses for existing drugs. It is a cost-effective and time-efficient approach to drug discovery, as it eliminates the need to develop a new drug from scratch. The process involves analyzing existing drugs and their effects on the body, and then using this data to identify potential new uses for the drug. This can include treating different diseases, or even using the drug in combination with other drugs to create a more effective    treatment.
Drug repositioning has become increasingly popular in recent years, as it can help reduce the cost and time associated with drug discovery. It also has the potential to reduce the risk of side effects, as the drug has already been tested and approved for use.
Companies in the drug repositioning market include GVK Biosciences, Novartis, Pfizer, and Johnson & Johnson. Show Less   Read more